# HDS Plus PBPC Transplant Vs 4 More Courses of FrontLine Therapy in Pts With Aggressive NHL in PR After Induction Therapy

> **NCT00866203** · PHASE3 · COMPLETED · sponsor: **Gruppo Italiano Studio Linfomi** · enrollment: 441 (actual)

## Conditions studied

- High-Grade Lymphomas

## Interventions

- **DRUG:** HDS vs ProMECE/CytaBOM

## Key facts

- **NCT ID:** NCT00866203
- **Lead sponsor:** Gruppo Italiano Studio Linfomi
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-10
- **Primary completion:** —
- **Final completion:** 2008-04
- **Target enrollment:** 441 (ACTUAL)
- **Last updated:** 2009-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00866203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00866203, "HDS Plus PBPC Transplant Vs 4 More Courses of FrontLine Therapy in Pts With Aggressive NHL in PR After Induction Therapy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00866203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*